Navigating The Regulatory Maze: Fundamentals For Drug Development

Navigating through the evolving regulatory landscape can be a challenge, especially for early-stage biotechnology companies developing a drug for the first time. In order to avoid unnecessary delays and find success in drug development, it is critical to understand and properly apply regulations. 

This white paper will offer descriptions of some key regulatory concepts and explores how to accelerate and reduce risk throughout the drug development journey. It will also highlight the difference between Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP).